Ä¢¹½ÊÓƵ

This new lecture unit will be delivered entirely by senior scientists from QIAGEN from their Global Development and Molecular Diagnostics division. Students will learn about current diagnostic concepts as well as how to translate advanced molecular technologies into future diagnostic techniques - as explained by commercial scientists working at the cutting edge of this process. The unit will cover both the science and the regulatory requirements necessary for such developments. Though running conventionally (i.e. in Stopford, with Podcasts, Blackboard and an internal Unit Coordinator) the unit is otherwise a unique and extremely exciting opportunity to hear directly from very senior scientists working at a major international Life Sciences company. This unit should be of special interest to the Biomedical Sciences (and related) and Biotechnology (and related) programmes as well as to those students doing an Enterprise project.

None. Helpful units include:BIOL21351: Molecules & Cells in Human DiseaseBIOL20902: Clinical Sciences RSM

To explore current approaches in medical diagnostics, as well as how to develop and obtain approval for future diagnostic techniques. To consider Translational Medicine and its possible impact on human healthcare.

•       Introduction to Medical DiagnosticsWhy is it needed? Overview of existing diagnostics:Patient interview (symptoms);In vivo imaging e.g. X-ray, PET, MRI; In vitro sampling (Blood, biopsy etc)Diagnostics performance - Sensitivity, Specificity, Precision.Positive & negative predictive values (PPV, NPV) •       Molecular Diagnostic (MDx) TechnologiesDNA-based e.g. (q)PCR, Sequencing (Sanger, Pyro, Next Gen/NGS)Syndromic testingProtein-based e.g. ELISA, ImmunohistochemistryMetabolite-based e.g. Chromatography (LC-MS)Diagnostic devices and formats; Companion diagnostics •       Medical Diagnostics - Regulatory Environments and RequirementsWhy regulation is necessary. Regulatory agencies in EU/US/CN/JP/AUSApproval process and requirements.Overview of US regulations - ASR, CLIA, 510k, PMA.Example of regulatory approval process for device and assay (FDA/CE documents)Typical development process and documentation requirementsPost-launch surveillanceImpact of regulatory processes - positive and negative on healthcare •       Translational Medicine OverviewRationale: translate new discoveries into clinical practice - improve human health. Definition (three pillars: benchside, bedside and community).Combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies.Future of Diagnostic MedicineMechanisms supporting this: Government, Commercial, Programs and organizations supporting translational science

800 word essay – 20% On campus written examination (80%), comprising 1 essay from a choice of 2.

Blackboard Discussion Board - checked regularly by Unit Coordinator.

There are no specific textbooks for this unit.

The year studying abroad is an integral part of the course and must be completed. Some costs, such as tuition fees, are substantially lower. Other costs can vary and are not included in the tuition fee. For example, living costs may be higher or lower than the UK, and there are travel-related costs to consider, such as paying for a passport, visa fees, health insurance, and (if needed) vaccinations.

All students should normally be able to complete their programme of study without incurring additional study costs over and above the tuition fee for that programme. Any unavoidable additional compulsory costs totalling more than 1% of the annual home undergraduate fee per annum, regardless of whether the programme in question is undergraduate or postgraduate taught, will be made clear to you at the point of application. Further information can be found in the University's (PDF document, 91KB).

Students participating in placements outside the UK may be able to apply for funding from the depending on eligibility. Priority will be given to students from low income households.